Cargando…
Exploring the impact of a decision support algorithm to improve clinicians’ chemotherapy-induced peripheral neuropathy assessment and management practices: a two-phase, longitudinal study
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) negatively affects physical function and chemotherapy dosing, yet, clinicians infrequently document CIPN assessment and/or adhere to evidence-based CIPN management in practice. The primary aims of this two-phase, pre-posttest study were t...
Autores principales: | Knoerl, Robert, Mazzola, Emanuele, Hong, Fangxin, Salehi, Elahe, McCleary, Nadine, Ligibel, Jennifer, Reyes, Kaitlen, Berry, Donna L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937225/ https://www.ncbi.nlm.nih.gov/pubmed/33676431 http://dx.doi.org/10.1186/s12885-021-07965-8 |
Ejemplares similares
-
Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors
por: Knoerl, Robert, et al.
Publicado: (2021) -
Identifying participants’ preferences for modifiable chemotherapy-induced peripheral neuropathy prevention clinical trial factors: an adaptive choice-based conjoint analysis
por: Knoerl, Robert, et al.
Publicado: (2022) -
Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial
por: Knoerl, Robert, et al.
Publicado: (2021) -
Impact of Electronic Self-Assessment and Self-Care Technology on Adherence to Clinician Recommendations and Self-Management Activity for Cancer Treatment–Related Symptoms: Secondary Analysis of a Randomized Controlled Trial
por: Knoerl, Robert, et al.
Publicado: (2019) -
What do the data say about chemotherapy-induced peripheral neuropathy assessment and management?
por: Kanzawa-Lee, Grace, et al.
Publicado: (2022)